Laureate Education, Inc. LAUR 深 滬
已收盤 02-06 16:00:00 美东时间
35.01
+0.540
+1.57%
華盛通- 最 高35.17
- 今 開34.79
- 成交量 74.16万股
- 最 低 34.60
- 昨 收 34.47
- 總市值 51.59亿
- 52周最高 36.34
- 市盈率 靜 18.17
- 換手率 0.50%
- 52周最低 17.908
- 委 比 -89.18%
- 總股本 1.47亿
- 歷史最高 36.34
- 量 比 0.62
- 振 幅 1.65%
- 歷史最低 5.92
- 每 手 1
- 風險率 5.24%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Laureate Education Announces Date of Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call
Laureate Education, Inc. will release its Q4 and FY2025 results on February 19, 2026, before the market opens, followed by a conference call at 8:30 a.m. ET. Interested parties can register to access dial-in details and join the call. The webcast, including replays, along with the earnings release and slides, will be available on the Investor Relations section of www.laureate.net. Laureate Education operates five higher education institutions in ...
01-20 21:15
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
UBS Maintains Buy on Laureate Education, Raises Price Target to $39
UBS analyst Andre Salles maintains Laureate Education (NASDAQ:LAUR) with a Buy and raises the price target from $36 to $39.
01-09 00:37
美股大行评级 | 超配！大摩上调回声星通信评级；汽车地带、CBRL、金宝汤、家得宝等遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8美元升至8.25美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12.5美元升至13美元
2025-12-11 10:33
JP Morgan Initiates Coverage On Laureate Education with Overweight Rating, Announces Price Target of $40
JP Morgan analyst Marcelo Santos initiates coverage on Laureate Education (NASDAQ:LAUR) with a Overweight rating and announces Price Target of $40.
2025-12-10 22:11
Here's How Much $1000 Invested In Laureate Education 5 Years Ago Would Be Worth Today
Laureate Education (NASDAQ:LAUR) has outperformed the market over the past 5 ye...
2025-11-14 00:45
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
2025-11-04 10:31
Laureate Education Boosts Stock Repurchase by $150 Million
The latest announcement is out from Laureate Education ( ($LAUR) ). On October ...
2025-10-30 19:27
Laureate Education Raises FY2025 Sales Guidance from $1.615B-$1.630B to $1.681B-$1.686B vs $1.636B Est
Laureate Education (NASDAQ:LAUR) raises FY2025 sales outlook from $1.615 billion-$1.630 billion to $1.681 billion-$1.686 billion vs $1.636 billion estimate.
2025-10-30 19:16
